Approval · Notice of Compliance 1262 · 2000
ARAVA: Notice of Compliance 1262
Issued March 16, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1262
- Date
- March 16, 2000
- Company
- Aventis Pharma Inc.Laval, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antirheumatic agent
Products in this notice
Medicinal ingredients
- LEFLUNOMIDE 10 MG per TAB
- LEFLUNOMIDE 20 MG per TAB
- LEFLUNOMIDE 100 MG per TAB